comparemela.com

Latest Breaking News On - Professor kenneth chien - Page 1 : comparemela.com

eTheRNA Raises €39M in Series B2 Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Steven powellKenneth chienNovalis lifesciencesBernard sagaertBayer agKarolinska instituteThermo fisher scientific incLife sciencesOmega fundProfessor kenneth chienGrand pharmaModerna therapeuticsMarijn dekkers

Millions in funding and new board members for Belgian mRNA company

An mRNA technologies company has raised €39 million ($38.7 million) in a series B2 financing and gained new board members.

Steven powellKenneth chienNovalis lifesciencesBernard sagaertKarolinska instituteLife sciencesOmega fundProfessor kenneth chienGrand pharmaModerna therapeuticsMarijn dekkers

eTheRNA Immunotherapies NV: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA

Financing round led by Novalis LifeSciences LLCBoth investors Dr. Marijn Dekkers and Moderna's co-founder Dr. Kenneth Chien to join the board of directorsStrategic focus includes customized lipid nanoparticles

Steven powellRussell greigKostenloser wertpapierhandelKenneth chienJohn frauncesBernard sagaertNovalis lifesciencesBayer agProfessor of the swedish research councilLifesci advisorsKarolinska instituteCompany contactThermo fisher scientific incLife sciencesOmega fundMarijn dekkers

vimarsana © 2020. All Rights Reserved.